Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis

NCT04368039 is registered in ClinicalTrials.gov with Nicholas Breitborde as lead sponsor.

NCT NCT04368039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04368039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis
Lead sponsor
Nicholas Breitborde
Phase
Not applicable
Overall status
Recruiting
Start date
December 4, 2019
Completion date
December 7, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

first-episode psychosis, psychosis, schizophrenia